Innate Pharma S.A. (IPHA) Q1 2025 Earnings Call Transcript
2025-05-13 13:51:34 ET
Innate Pharma S.A. (IPHA)
Q1 2025 Earnings Conference Call
May 13, 2025 8:00 am ET
Corporate Participants
Henry Wheeler - VP, IR and Communications
Jonathan Dickinson - Chief Executive Officer
Yannis Morel - Chief Operating Officer
Sonia Quaratino - Chief Medical Officer
Frederic Lombard - Chief Financial Officer
Conference Call Participants
Daina Graybosch - Leerink Partners
Swayampakula Ramakanth - H.C. Wainwright
Rajan Sharma - Goldman Sachs
Presentation
Operator
Hello, and thank you for standing by. My name is Lacey, and I will be your conference operator today. At this time, I would like to welcome everyone to the Innate Pharma First Quarter 2025 Financial Results and Business Update Conference Call.
[Operator Instructions]. Thank you.
I would now like to turn the call over to Henry Wheeler, Vice President of Investor Relations. You may go ahead....
Read the full article on Seeking Alpha
For further details see:
Innate Pharma S.A. (IPHA) Q1 2025 Earnings Call TranscriptNASDAQ: IPHA
IPHA Trading
-0.63% G/L:
$1.59 Last:
13,204 Volume:
$1.60 Open:



